A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study To Investigate The Safety And Efficacy Of CP-690,550 For Maintenance Therapy In Subjects With Moderate To Severe Crohn's Disease
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centre Study To Investigate The Safety And Efficacy Of CP-690,550 For Maintenance Therapy In Subjects With Moderate To Severe Crohn's Disease
This study investigates safety and efficacy of CP-690,550 in adult patients with moderate to severe Crohn's disease who completed the double-blind induction treatment in Study A3921083 and achieved clinical response-100 and/or clinical remission (CDAI<150) at Week 8.
Inclusion Criteria:
Exclusion Criteria:
Gainsville, Florida 32610, United States
Cleveland, Ohio 44106, United States
Washington DC, Virginia 20006, United States
Milwaukee, Wisconsin 53215, United States
Kolonaki Athens, 106 76, Greece
Budapest, 1125, Hungary
Budapest, H-1076, Hungary
Hokkaido, 060-0033, Japan
Seoul, 135-710, South Korea
Seoul, 138-736, South Korea
Donetsk, 83017, Ukraine
Odesa, 65117, Ukraine